Exact Mass: 339.1998

Exact Mass Matches: 339.1998

Found 95 metabolites which its exact mass value is equals to given mass value 339.1998, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Methylergonovine

Methylergometrine

C20H25N3O2 (339.1947)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

Methylergonovine

(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

C20H25N3O2 (339.1947)


Methylergonovine is only found in individuals that have used or taken this drug. It is a homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)Methylergonovine acts directly on the smooth muscle of the uterus and increases the tone, rate, and amplitude of rhythmic contractions through binding and the resultant antagonism of the dopamine D1 receptor. Thus, it induces a rapid and sustained tetanic uterotonic effect which shortens the third stage of labor and reduces blood loss. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

Bursin

2,6-Diamino-N-(1-{[(C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-2-(1H-imidazol-5-yl)ethyl)hexanimidate

C14H25N7O3 (339.2019)


   

Bursopoietin

2,6-Diamino-N-(1-{[(C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-2-(4H-imidazol-4-yl)ethyl)hexanimidate

C14H25N7O3 (339.2019)


   

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C20H25N3O2 (339.1947)


   

1',3'-Dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one

1,5-dimethyl-17-oxa-7-azaspiro[1,5-diazinane-2,4-tetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadecane]-1(10),11,13,15-tetraen-6-one

C20H25N3O2 (339.1947)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   
   

Maybridge3_005319

Maybridge3_005319

C20H25N3O2 (339.1947)


   
   

9-O-(erythro-2-hydroxy-2-methyl-3-tigloyloxy-butyryl)-(-)-trachelanthamidine|minalobine O

9-O-(erythro-2-hydroxy-2-methyl-3-tigloyloxy-butyryl)-(-)-trachelanthamidine|minalobine O

C18H29NO5 (339.2046)


   

6beta-Isovaleryloxy-3alpha-tigloyloxy-tropanol-(7beta)

6beta-Isovaleryloxy-3alpha-tigloyloxy-tropanol-(7beta)

C18H29NO5 (339.2046)


   

neorosmarinine

neorosmarinine

C18H29NO5 (339.2046)


   
   
   
   
   
   
   

Pimelic Diphenylamide 106

N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide

C20H25N3O2 (339.1947)


   
   
   

BML-210

N-(2-aminophenyl)-N-phenyl-octanediamide

C20H25N3O2 (339.1947)


   
   
   

(+)-7-epi-12-hydroxyjasmonoyl-L-isoleucine

(+)-7-epi-12-hydroxyjasmonoyl-L-isoleucine

C18H29NO5 (339.2046)


   
   

Methylergometrine

Methylergometrine

C20H25N3O2 (339.1947)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.459 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.457 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.450 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.451

   

Vincadifformine

Vincadifformine

[C21H27N2O2]+ (339.2072)


Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids

   
   
   
   
   
   
   
   
   

Dodecyl 3-amino-4-chlorobenzoate

Dodecyl 3-amino-4-chlorobenzoate

C19H30ClNO2 (339.1965)


   
   

4-Hexyl-1,1:4,1-terphenyl-4-carbonitrile

4-Hexyl-1,1:4,1-terphenyl-4-carbonitrile

C25H25N (339.1987)


   

N-METHYLSARPAGINE METHOSALT

N-METHYLSARPAGINE METHOSALT

C21H27N2O2+ (339.2072)


   

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

C20H25N3O2 (339.1947)


   

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

C20H25N3O2 (339.1947)


   

(4-Fluorophenyl)-[1-(4-phenylbutyl)piperidin-4-yl]methanone

(4-Fluorophenyl)-[1-(4-phenylbutyl)piperidin-4-yl]methanone

C22H26FNO (339.1998)


   

N1-(2-aminophenyl)-N8-phenyloctanediamide

N1-(2-aminophenyl)-N8-phenyloctanediamide

C20H25N3O2 (339.1947)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C20H25N3O2 (339.1947)


   

N-({(1R,2S)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

N-({(1R,2S)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

C18H29NO5 (339.2046)


   

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-[3-(methylazaniumyl)propyl]azanium

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-[3-(methylazaniumyl)propyl]azanium

C14H25N7O3+2 (339.2019)


   

methyl (1S,12R,19S)-12-ethyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1S,12R,19S)-12-ethyl-8-aza-16-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C21H27N2O2+ (339.2072)


   

9-[6(S),9-diamino-5,6,7,8,9-pentadeoxy-beta-D-ribo-nonafuranosyl]-9H-purin-6-amine

9-[6(S),9-diamino-5,6,7,8,9-pentadeoxy-beta-D-ribo-nonafuranosyl]-9H-purin-6-amine

C14H25N7O3+2 (339.2019)


   

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

C15H25N5O4 (339.1906)


   

Vincadifformine(1+)

Vincadifformine(1+)

C21H27N2O2+ (339.2072)


   

(+)-Vincadifformine(1+)

(+)-Vincadifformine(1+)

C21H27N2O2+ (339.2072)


An ammonium ion resulting from the protonation of the tertiary amino group of (+)-vincadifformine. The major species at pH 7.3.

   

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

C20H25N3O2 (339.1947)


   

N-[2-[2-(dibutylamino)ethylamino]-2-oxoethyl]-2-thiophenecarboxamide

N-[2-[2-(dibutylamino)ethylamino]-2-oxoethyl]-2-thiophenecarboxamide

C17H29N3O2S (339.198)


   
   
   
   
   
   

Secodine(1+)

Secodine(1+)

C21H27N2O2+ (339.2072)


A tertiary ammonium ion that is the conjugate acid of secodine, obtained by protonation of the nitrogen atom of the tetrahydropyridine moiety. The major microspecies at pH 7.3.

   
   

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.1947)


   

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.1947)


   

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.1947)


   
   
   
   
   
   
   

N-({(1R)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

N-({(1R)-2-[(2Z)-5-hydroxypent-2-en-1-yl]-3-oxocyclopentyl}acetyl)-L-isoleucine

C18H29NO5 (339.2046)


   

methyl (19S)-12-ethyl-16-aza-8-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9-tetraene-10-carboxylate

methyl (19S)-12-ethyl-16-aza-8-azoniapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9-tetraene-10-carboxylate

C21H27N2O2+ (339.2072)


   

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C20H25N3O2 (339.1947)


   

Methergine

Methergine

C20H25N3O2 (339.1947)


D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

(-)-vincadifformine(1+)

(-)-vincadifformine(1+)

C21H27N2O2 (339.2072)


An ammonium ion resulting from the protonation of the tertiary amino group of (-)-vincadifformine. The major species at pH 7.3.

   

(-)-coronaridine(1+)

(-)-coronaridine(1+)

C21H27N2O2 (339.2072)


An ammonium ion derivative resulting from the protonation of the tertiary amino group of (-)-coronaridine.

   

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C20H25N3O2 (339.1947)


   

N-[(+)-12-hydroxy-7-isojasmonyl]isoleucine

N-[(+)-12-hydroxy-7-isojasmonyl]isoleucine

C18H29NO5 (339.2046)


An L-isoleucine derivative resulting from the formal condensation of the carboxy group of (+)-12-hydroxy-7-isojasmonic acid with the amino group of L-isoleucine.

   
   
   

KYP-2047

KYP-2047

C20H25N3O2 (339.1947)


KYP-2047 is a potent and BBB-penetrating prolyl-oligopeptidase (POP) inhibitor, with an Ki value of 0.023 nM. KYP-2047 reduces glioblastoma proliferation through angiogenesis and apoptosis modulation[1][2].

   

SEN12333

SEN12333

C20H25N3O2 (339.1947)


SEN 12333 (WAY-317538) is a potent, selective and orally active α7 nAChR agonist. SEN12333 displays high affinity for the rat α7 nAChRs expressed in GH4C1 cells (K>i=260 nM) and acts as full agonist in functional Ca2+ flux studies (EC50=1.6 μM). SEN 12333 is used for AD and schizophrenia research[1].

   

10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl 1-methylpyrrolidine-2-carboxylate

10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl 1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.1965)


   

(1s,3r,5r,6r,7s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1s,3r,5r,6r,7s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.1965)


   

(2s,13s,15r,16r,19r,20r,21r)-21-hydroxy-1,11,19-trimethyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-1-ium

(2s,13s,15r,16r,19r,20r,21r)-21-hydroxy-1,11,19-trimethyl-18-oxa-1,11-diazahexacyclo[11.8.0.0²,¹⁶.0⁴,¹².0⁵,¹⁰.0¹⁵,²⁰]henicosa-4(12),5,7,9-tetraen-1-ium

[C21H27N2O2]+ (339.2072)


   

(3r,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(3r,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.1965)


   

(3s,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(3s,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.1965)


   

(2r,3s)-4-[(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethoxy]-3-hydroxy-3-methyl-4-oxobutan-2-yl (2e)-2-methylbut-2-enoate

(2r,3s)-4-[(1r,7as)-hexahydro-1h-pyrrolizin-1-ylmethoxy]-3-hydroxy-3-methyl-4-oxobutan-2-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

(3r)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(3r)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enoate

6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

(3s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(3s)-6-hydroxy-8-methyl-7-[(3-methylbutanoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

4-(hexahydro-1h-pyrrolizin-1-ylmethoxy)-3-hydroxy-3-methyl-4-oxobutan-2-yl 2-methylbut-2-enoate

4-(hexahydro-1h-pyrrolizin-1-ylmethoxy)-3-hydroxy-3-methyl-4-oxobutan-2-yl 2-methylbut-2-enoate

C18H29NO5 (339.2046)


   

4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

C18H29NO5 (339.2046)


   

(1r,4e,6r,7r,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

(1r,4e,6r,7r,11s,12s,17r)-4-ethylidene-7,12-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecan-8-one

C18H29NO5 (339.2046)